YPL-001

· Yungjin Pharm. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YPL-001, covering 2021-06-25 to 2021-06-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients [Phase 2]